Sigma Planning Corp cut its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 25.8% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 15,203 shares of the exchange traded fund’s stock after selling 5,285 shares during the quarter. Sigma Planning Corp’s holdings in SPDR S&P Biotech ETF were worth $1,942,000 at the end of the most recent reporting period.
Other hedge funds have also bought and sold shares of the company. Financial Life Planners bought a new stake in SPDR S&P Biotech ETF during the first quarter valued at $27,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new position in shares of SPDR S&P Biotech ETF in the 4th quarter valued at about $27,000. Intesa Sanpaolo Wealth Management acquired a new position in shares of SPDR S&P Biotech ETF in the 4th quarter valued at about $30,000. SHP Wealth Management bought a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter valued at about $31,000. Finally, Legacy Wealth Managment LLC ID bought a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter valued at about $32,000.
SPDR S&P Biotech ETF Price Performance
NYSEARCA XBI opened at $152.00 on Friday. The stock has a market capitalization of $10.34 billion, a P/E ratio of 11.47 and a beta of 0.82. The business has a 50 day simple moving average of $142.06 and a 200 day simple moving average of $132.23. SPDR S&P Biotech ETF has a one year low of $84.39 and a one year high of $165.71.
SPDR S&P Biotech ETF Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Featured Stories
- Five stocks we like better than SPDR S&P Biotech ETF
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
- Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
- Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
